Text Size

In-Room PET in Proton Radiation Therapy

This study is currently recruiting participants.
Verified May 2013 by Massachusetts General Hospital
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Helen A. Shih, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01228448
First received: October 25, 2010
Last updated: May 2, 2013
Last verified: May 2013
History of Changes
  Purpose

The investigational part of this study is using a mobile PET scanner called NeuroPET to take images of the participants tumor while they are receiving proton radiation treatment. This allows the participant to be treated and imaged in the same bed. The information obtained may improve the accuracy of treatment and may help to minimize the dose delivered unnecessarily to healthy tissue.


Condition Intervention
Brain Tumor
Head and Neck Tumor
Skull Base Tumor
 Procedure: PET scan

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Pilot Study of In-Room PET in Proton Radiation Therapy

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Massachusetts General Hospital:

Primary Outcome Measures:
  • Effectiveness [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Acquire PET scan data in list-mode on patients undergoing external beam proton radiotherapy for brain and soft tissue tumors in head. Analyze these data to assess the effectiveness of using NeuroPET for in-room PET monitoring or proton radiation therapy quality assurance.


Secondary Outcome Measures:
  • Optimize the in-room PET acquisition length [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Reconstruct these list-mode PET data for different scan durations and optimize in-room PET acquisition length


Estimated Enrollment: 30
Study Start Date: October 2010
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Participants 1-24
PET Scan done right after the first radiation treatment is complete and will take 15-20 minutes. The scan will then be performed three more times.
 Procedure: PET scan
In-Room PET scan
Experimental: Participants 25-27
20 minute PET scan done after the first dose of radiation given to the tumor.
 Procedure: PET scan
In-Room PET scan
Experimental: Participants 28-30
5-10 minute PET scan will be done after the delivery of the first dose of radiation, and a 15-20 minute PET scan will be done after the delivery of the second dose of radiation.
 Procedure: PET scan
In-Room PET scan

Detailed Description:
  • Depending upon when the participant enrolls in the study, they will have anywhere from 1 to 4 in-room PET scans during proton radiation treatment. There are three groups.
  • Group 1: A total of 24 participants in the study will have a PET scan right after their first radiation treatment is completed. The scan will take 15-20 minutes. For 5 of the first 19 participants, the PET scan will be performed three more times within a week (Monday, Wednesday, Friday). For participants 20-24 the scan will be performed three times in the 1st, 3rd and 5th weeks.
  • Group 2: Three participants will have a 20 minute PET scan done after the first dose of radiation given to the tumor.
  • Group 3: Three participants will have a 5-20 minute PET scan done after the delivery of the first dose of radiation, and a 15-20 minute PET scan will be done after the delivery of the second dose of radiation.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult subjects with brain, head and neck, and skull base tumors receiving external beam proton radiotherapy at the Francis H. Burr Proton Therapy Center at MGH
  • Age 18 or over
  • ECOG Performance status 0, 1 or 2
  • Subjects must have internal CT markers implanted on the skull as part of their radiation treatment planning

Exclusion Criteria:

  • Uncontrolled intercurrent illness that, in the opinion of the investigator, would limit the participant's compliance with study requirements.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01228448

Contacts
Contact: Helen A. Shih, MD 617-643-7250 hshih@partners.org

Locations
United States, Massachusetts
Massachusetts General Hospital Recruiting
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
National Cancer Institute (NCI)
Investigators
Principal Investigator: Helen A. Shih, MD Massachusetts General Hospital
  More Information

No publications provided

Responsible Party: Helen A. Shih, MD, Attending Radiation Oncologist, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT01228448     History of Changes
Other Study ID Numbers: 10-241
Study First Received: October 25, 2010
Last Updated: May 2, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
external beam proton radiotherapy
PET

Additional relevant MeSH terms:
Brain Neoplasms
Head and Neck Neoplasms
Skull Base Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Neoplasms
 Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Skull Neoplasms
Bone Neoplasms
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on May 21, 2013